Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REMOVAL: Metformin to reduce vascular complications in type 1 diabetes
2011-000300-18Phase 3Completed
- Sponsor
- NHS Greater Glasgow and Clyde
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in diabetes mellitus type 1 (T1D) and cardiac morbidity comparing Metformin + insulin with Placebo + insulin (2 arms). Primary endpoint: Progression of carotid intima-media thickness (cIMT). Started Aug 2011; status: completed.
02
Drugs
metformin
03
Conditions
diabetes mellitus type 1 (T1D)cardiac morbidity
Beyond the preview
Go deeper on 2011-000300-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000300-18.